.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

REVATIO Drug Profile

« Back to Dashboard
Revatio is a drug marketed by Pfizer and is included in three NDAs. It is available from two suppliers.

The generic ingredient in REVATIO is sildenafil citrate. There are twenty drug master file entries for this compound. Thirty-two suppliers are listed for this compound. There are eleven tentative approvals for this compound. Additional details are available on the sildenafil citrate profile page.

Summary for Tradename: REVATIO

Patents:0
Applicants:1
NDAs:3
Suppliers / Packagers: see list2
Drug Prices: :see details

Pharmacology for Tradename: REVATIO

Clinical Trials for: REVATIO

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
REVATIO
sildenafil citrate
FOR SUSPENSION;ORAL203109-001Aug 30, 2012RXYesAug 30, 2015
Pfizer
REVATIO
sildenafil citrate
TABLET;ORAL021845-001Jun 3, 2005RXYesJan 31, 2017
Pfizer
REVATIO
sildenafil citrate
FOR SUSPENSION;ORAL203109-001Aug 30, 2012RXYesMar 1, 2016
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: REVATIO

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
REVATIO
sildenafil citrate
TABLET;ORAL021845-001Jun 3, 20055,250,534*PED<disabled>
Pfizer
REVATIO
sildenafil citrate
SOLUTION;INTRAVENOUS022473-001Nov 18, 20095,250,534*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc